Shufro Rose & Co. LLC Grows Stake in The Procter & Gamble Company (NYSE:PG)

Shufro Rose & Co. LLC raised its holdings in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 14.4% in the 4th quarter, Holdings Channel reports. The institutional investor owned 3,964 shares of the company’s stock after purchasing an additional 500 shares during the quarter. Shufro Rose & Co. LLC’s holdings in Procter & Gamble were worth $578,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of PG. Naples Money Management LLC acquired a new position in shares of Procter & Gamble in the 4th quarter valued at $29,000. Wyrmwood Management LLC acquired a new position in shares of Procter & Gamble in the 4th quarter valued at $29,000. Criterion Capital Advisors LLC acquired a new position in shares of Procter & Gamble in the 4th quarter valued at $33,000. Mendota Financial Group LLC increased its position in shares of Procter & Gamble by 636.6% in the 4th quarter. Mendota Financial Group LLC now owns 302 shares of the company’s stock valued at $44,000 after acquiring an additional 261 shares during the period. Finally, Morton Brown Family Wealth LLC boosted its holdings in Procter & Gamble by 206.6% in the fourth quarter. Morton Brown Family Wealth LLC now owns 417 shares of the company’s stock valued at $61,000 after purchasing an additional 281 shares during the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Procter & Gamble Price Performance

NYSE PG traded down $1.26 on Friday, hitting $161.29. 5,659,784 shares of the company were exchanged, compared to its average volume of 6,820,118. The firm has a 50 day moving average of $159.64 and a two-hundred day moving average of $153.57. The company has a market cap of $380.67 billion, a P/E ratio of 26.35, a P/E/G ratio of 3.27 and a beta of 0.44. The company has a current ratio of 0.69, a quick ratio of 0.48 and a debt-to-equity ratio of 0.49. The Procter & Gamble Company has a 1-year low of $141.45 and a 1-year high of $164.32.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings results on Friday, April 19th. The company reported $1.52 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.10. Procter & Gamble had a net margin of 18.00% and a return on equity of 33.91%. The company had revenue of $20.20 billion during the quarter, compared to analysts’ expectations of $20.43 billion. During the same period last year, the business earned $1.37 EPS. The business’s quarterly revenue was up .6% on a year-over-year basis. On average, equities analysts predict that The Procter & Gamble Company will post 6.55 EPS for the current year.

Procter & Gamble Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be given a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a yield of 2.50%. The ex-dividend date of this dividend is Thursday, April 18th. This is a boost from Procter & Gamble’s previous quarterly dividend of $0.94. Procter & Gamble’s payout ratio is currently 65.69%.

Insider Buying and Selling at Procter & Gamble

In other news, insider Balaji Purushothaman sold 28,369 shares of the business’s stock in a transaction dated Tuesday, April 23rd. The stock was sold at an average price of $161.49, for a total transaction of $4,581,309.81. Following the sale, the insider now directly owns 11,507 shares in the company, valued at $1,858,265.43. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other Procter & Gamble news, insider Balaji Purushothaman sold 28,369 shares of the business’s stock in a transaction that occurred on Tuesday, April 23rd. The stock was sold at an average price of $161.49, for a total value of $4,581,309.81. Following the transaction, the insider now directly owns 11,507 shares of the company’s stock, valued at $1,858,265.43. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO R. Alexandra Keith sold 855 shares of the company’s stock in a transaction on Monday, April 22nd. The stock was sold at an average price of $158.50, for a total value of $135,517.50. Following the sale, the chief executive officer now owns 4,004 shares of the company’s stock, valued at approximately $634,634. The disclosure for this sale can be found here. Insiders have sold a total of 100,865 shares of company stock worth $16,029,280 over the last 90 days. Insiders own 0.17% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the stock. Raymond James increased their target price on shares of Procter & Gamble from $170.00 to $175.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 24th. Royal Bank of Canada increased their price objective on shares of Procter & Gamble from $156.00 to $157.00 and gave the stock a “sector perform” rating in a research report on Wednesday, January 24th. Truist Financial raised shares of Procter & Gamble from a “hold” rating to a “buy” rating and raised their price target for the company from $160.00 to $175.00 in a research report on Monday, March 11th. The Goldman Sachs Group started coverage on shares of Procter & Gamble in a research report on Friday, March 1st. They set a “neutral” rating and a $168.00 price objective for the company. Finally, Jefferies Financial Group lifted their price target on shares of Procter & Gamble from $175.00 to $182.00 and gave the stock a “buy” rating in a research note on Monday, April 22nd. Seven analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. Based on data from MarketBeat, Procter & Gamble has an average rating of “Moderate Buy” and an average target price of $169.76.

Get Our Latest Report on Procter & Gamble

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Featured Articles

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.